object
determin
risk
seriou
bacteri
infect
sbi
young
febril
infant
without
viral
infect
studi
design
plan
secondari
analys
prospect
observ
studi
febril
infant
day
age
younger
evalu
emerg
depart
clinic
sepsi
identifi
site
bacteri
infect
compar
patient
demograph
clinic
laboratori
find
preval
sbi
virusposit
virusneg
infant
enrol
infant
viral
test
perform
viru
posit
sbi
ci
virusneg
infant
sbi
ci
rate
specif
sbi
virusposit
group
vs
virusneg
group
uti
ci
vs
ci
bacteremia
ci
vs
ci
rate
bacteri
mening
tend
lower
virusposit
group
viralneg
group
differ
statist
signific
neg
viral
statu
aor
ci
significantli
associ
sbi
multivari
analysi
conclus
febril
infant
day
age
viral
infect
significantli
lower
nonneglig
risk
sbi
includ
bacteremia
bacteri
mening
j
pediatr
pproxim
infant
day
age
younger
evalu
annual
emerg
depart
ed
us
fever
infant
confirm
bacteri
infect
document
viral
infect
rel
immatur
immun
system
young
infant
predispos
develop
invas
bacteri
ill
bacteremia
bacteri
mening
mani
also
develop
urinari
tract
infect
uti
collect
infect
refer
seriou
bacteri
infect
sbi
expert
guidanc
manag
includ
obtain
blood
screen
test
may
includ
white
blood
cell
count
absolut
neutrophil
count
anc
band
count
serum
procalcitonin
creactiv
protein
concentr
addit
urinalysi
evalu
cerebrospin
fluid
csf
well
cultur
fluid
primarili
previou
literatur
demonstr
clinic
examin
limit
establish
precis
diagnosi
exclud
diagnos
febril
infant
blood
urin
csf
cultur
refer
standard
confirm
sbi
mani
clinician
treat
young
febril
infant
empir
antibiot
intraven
often
hospit
young
infant
bacteri
cultur
result
avail
owe
widespread
avail
rapid
turnaround
pointofcar
test
viral
infect
mani
clinician
less
like
perform
comprehens
evalu
sbi
presenc
confirm
viral
infect
risk
sbi
shown
lower
among
infant
come
attent
fever
confirm
viral
infect
howev
previou
studi
attempt
determin
risk
sbi
among
young
febril
infant
viral
infect
conduct
small
cohort
retrospect
studi
design
limit
singl
viral
infect
andor
perform
decad
ago
plan
subanalysi
larg
multicent
prospect
cohort
studi
febril
infant
day
younger
evalu
sbi
compar
risk
sbi
virusposit
virusneg
infant
perform
plan
secondari
analysi
prospect
observ
cohort
studi
conveni
sampl
febril
infant
day
age
younger
evalu
presenc
sbi
least
blood
cultur
ed
pediatr
emerg
care
appli
research
network
pecarn
decemb
may
method
parent
studi
report
previous
institut
review
board
particip
site
approv
studi
elig
infant
enrol
inform
consent
obtain
parentsguardian
particip
method
pertin
secondari
analysi
describ
herein
enrol
febril
infant
defin
ed
rectal
temperatur
temperatur
similar
degre
measur
home
refer
clinic
evalu
ed
laboratori
evalu
includ
blood
urin
andor
csf
cultur
addit
test
sbi
infant
evalu
secondari
analysi
test
presenc
least
viral
infect
exclud
infant
clinic
sign
sepsi
prematur
major
system
comorbid
eg
seriou
congenit
abnorm
inborn
error
metabol
clear
evid
focal
bacteri
infect
includ
otiti
media
manag
febril
infant
controversi
patient
clinician
prospect
record
patient
demograph
physic
examin
find
includ
yale
observ
scale
yo
score
laboratori
test
result
yo
clinic
score
provid
quantit
assess
well
clinic
risk
sbi
febril
infant
toddler
base
simpl
clinic
observ
find
yo
score
less
consid
normal
test
presenc
viral
infect
perform
discret
individu
clinician
variabl
across
site
regard
type
number
viral
studi
perform
rang
test
individu
season
virus
respiratori
syncyti
viru
rsv
influenza
winter
month
comprehens
respiratori
viral
panel
main
outcom
diagnosi
sbi
defin
presenc
bacteri
mening
bacteremia
uti
combin
infect
patient
consid
sbi
blood
urin
cultur
neg
patient
exclud
main
sbi
analysi
either
blood
urin
cultur
result
neg
mening
statu
unknown
howev
cultur
posit
patient
consid
sbi
defin
bacteremia
bacteri
mening
growth
known
pathogen
blood
csf
respect
patient
lumbar
punctur
perform
includ
analysi
bacteri
mening
avail
telephon
followup
categor
patient
bacteri
mening
well
time
telephon
followup
cultur
growth
multipl
bacteria
commonli
consid
pathogen
eg
coagulaseneg
staphylococcu
diphtheroid
bacillu
speci
viridan
streptococci
categor
contamin
consid
neg
analysi
sbi
defin
uti
growth
singl
pathogen
urin
coloni
count
meet
criteria
greater
cfuml
specimen
obtain
suprapub
aspir
greater
cfuml
catheter
specimen
greater
cfuml
catheter
specimen
associ
abnorm
urinalysi
posit
leukocyt
esteras
nitrit
white
blood
cell
per
highpow
field
microscop
examin
unspun
urin
also
categor
febril
infant
purpos
analysi
basi
result
viral
test
viru
posit
viru
neg
compar
patient
demograph
histori
physic
examin
find
laboratori
result
preval
sbi
virusposit
virusneg
infant
also
compar
risk
sbi
viralposit
virusneg
infant
stratifi
age
day
vs
day
age
analyz
continu
variabl
use
student
test
categor
data
use
risk
differ
ordin
variabl
compar
use
wilcoxon
ranksum
test
also
compar
rate
sbi
individu
type
viru
detect
final
perform
multivari
logist
regress
analysi
assess
associ
viral
infect
sbi
adjust
patient
age
temperatur
yo
complet
blood
count
anc
statist
test
tail
statist
signific
design
p
statist
analys
perform
use
volum
decemb
sa
softwar
version
sa
institut
inc
cari
north
carolina
total
febril
infant
enrol
parent
studi
viral
test
perform
total
patient
singl
viral
test
perform
test
virus
comprehens
respiratori
panel
test
abl
ascertain
viral
test
result
sbi
statu
febril
infant
infant
includ
analysi
infant
viral
test
perform
among
abl
ascertain
sbi
statu
nonanalyt
cohort
overal
rate
sbi
virusnot
test
cohort
ci
mean
age
infant
evalu
secondari
analysi
day
mean
temperatur
infant
day
age
younger
characterist
virusposit
virusneg
infant
describ
tabl
virusneg
infant
like
day
age
younger
higher
mean
white
blood
cell
count
anc
count
viralposit
infant
tabl
ii
describ
variou
type
viral
test
perform
enrol
patient
across
particip
ed
overal
infant
analyz
ci
sbi
includ
ci
uti
ci
bacteremia
ci
bacteri
mening
addit
infant
uti
ci
also
bacteremia
ci
bacteremia
yield
absolut
risk
differ
ci
rate
specif
sbi
includ
uti
bacteremia
significantli
lower
virusposit
infant
compar
virusneg
infant
tabl
iii
although
rate
bacteri
mening
tend
lower
virusposit
group
virusneg
group
differ
statist
signific
tabl
iii
stratifi
age
group
regardless
viru
statu
overal
rate
sbi
febril
infant
day
age
younger
compar
among
infant
older
day
age
differ
ci
virusposit
infant
day
age
younger
lower
rate
sbi
virusneg
infant
age
cohort
tabl
iv
rate
sbi
infant
consist
lower
virusposit
group
regardless
specif
virus
identifi
compar
virusneg
infant
tabl
v
avail
wwwjpedscom
multivari
analysi
sbi
statu
depend
variabl
variabl
significantli
associ
sbi
virusneg
statu
aor
ci
age
day
younger
aor
ci
temperatur
aor
everi
increas
ci
anc
aor
everi
cellsmm
increas
ci
tabl
vi
avail
www
jpedscom
provid
detail
regard
bacteria
virus
identifi
studi
cohort
larg
multicent
studi
demonstr
infant
day
old
younger
come
medic
attent
fever
confirm
viral
infect
substanti
lower
risk
sbi
virusneg
infant
howev
nonneglig
rate
sbi
includ
rate
invas
bacteri
infect
bacteremia
mening
virusposit
febril
infant
taken
consider
clinic
decis
make
regard
evalu
manag
disposit
mani
young
febril
infant
viral
presum
viral
infect
sever
previou
studi
similarli
reveal
lower
risk
sbi
among
febril
infant
document
viral
infect
compar
earlier
studi
current
studi
larg
prospect
statist
power
provid
precis
estim
rate
previou
multicent
prospect
studi
febril
infant
day
old
younger
without
document
rsv
infect
reveal
uti
bacteremia
rate
respect
rsvposit
infant
compar
rsvneg
infant
separ
subanalysi
cohort
lower
rate
sbi
invas
bacteri
infect
also
document
influenzaposit
febril
infant
compar
infant
without
document
influenza
infect
similar
find
current
studi
studi
use
retrospect
cohort
similarli
reveal
lower
preval
sbi
among
virusposit
febril
infant
substanti
practic
pattern
variat
exist
evalu
young
febril
infant
influenc
increas
avail
multiplex
panel
rapid
turnaround
viral
test
studi
reveal
provid
frequent
chang
behavior
awar
result
viral
test
furthermor
virusposit
febril
infant
less
like
receiv
empir
antibiot
hospit
like
receiv
antivir
therapi
recent
survey
ed
inpati
clinician
canadian
pediatr
center
use
febril
infant
case
scenario
highlight
substanti
variat
evalu
manag
febril
infant
base
result
viral
test
survey
hospit
rate
infant
detect
respiratori
viru
decreas
p
percentag
column
repres
proport
infant
type
sbi
stratifi
age
categori
individu
type
sbi
origin
articl
infant
p
treatment
empir
antibiot
also
decreas
detect
respiratori
viru
infant
vs
p
infant
vs
p
despit
lower
preval
sbi
among
virusposit
febril
infant
document
current
earlier
studi
implic
clinician
straightforward
investig
suggest
perform
comprehens
evalu
sbi
especi
lumbar
punctur
avoid
presenc
document
viral
infect
wellappear
young
febril
infant
use
empir
antibiot
hospit
reconsid
other
suggest
practic
base
age
infant
full
evalu
sbi
includ
lumbar
punctur
first
month
life
despit
presenc
viral
infect
sbi
rate
remain
nonneglig
highest
risk
age
group
abil
determin
well
yo
limit
studi
find
add
current
knowledg
regard
epidemiolog
sbi
well
risk
sbi
among
virusposit
febril
infant
strength
current
studi
includ
larg
geograph
divers
prospect
cohort
febril
infant
comprehens
evalu
sbi
risk
estim
sbi
therefor
precis
generaliz
previou
studi
furthermor
limit
studi
singl
viru
individu
viral
ill
bronchiol
influenza
data
identifi
nonneglig
risk
bacteremia
bacteri
mening
first
month
life
suggest
clinician
need
exercis
caution
especi
first
month
life
regard
comprehens
evalu
includ
perform
lumbar
punctur
regardless
viru
infect
statu
age
group
minimum
evalu
uti
collect
sampl
urinalysi
urin
cultur
strongli
consid
regardless
viral
statu
final
studi
suggest
import
incorpor
result
viral
test
provid
better
risk
estim
sbi
infant
assist
clinician
decis
regard
lumbar
punctur
empir
antibiot
treatment
hospit
formal
decis
analys
costeffect
analys
use
data
help
develop
recommend
regard
viral
test
impact
part
evalu
manag
young
febril
infant
studi
sever
limit
first
parent
studi
cohort
consist
conveni
sampl
febril
infant
viral
test
perform
discret
treat
clinician
time
rapid
test
evolv
furthermor
number
virus
detect
type
test
perform
vari
site
season
type
test
name
polymeras
chain
reaction
vs
whether
singl
viral
test
multiplex
viral
polymeras
chain
reaction
panel
test
perform
type
specimen
nasal
swab
vs
throat
swab
tissu
fluid
sampl
csf
vs
blood
vs
respiratori
secret
possibl
rate
sbi
preval
viral
infect
detect
would
differ
comprehens
viral
test
perform
patient
higher
sensit
specif
viral
test
use
therefor
comment
exact
preval
viral
infect
studi
cohort
howev
higher
current
virusneg
patient
sbi
may
viru
posit
sbi
could
increas
rate
coinfect
thu
strengthen
conclus
addit
possibl
risk
sbi
may
vari
type
viral
infect
number
viral
coinfect
despit
limit
rate
sbi
enrol
popul
remark
similar
describ
previou
studi
second
intent
exclud
febril
infant
obviou
sourc
bacteri
infect
cellul
critic
illappear
infant
infant
repres
less
signific
diagnost
therapeut
conundrum
purpos
studi
identifi
risk
sbi
noncrit
illappear
febril
infant
confirm
viral
infect
aid
clinician
decis
make
third
analysi
stratifi
type
viral
infect
suffici
power
detect
statist
signific
differ
risk
sbi
viru
type
nevertheless
result
hypothesi
gener
despit
substanti
size
multicent
design
studi
also
suffici
statist
power
comment
risk
differ
bacteri
mening
virusposit
virusneg
infant
therefor
suggest
clinician
retain
low
threshold
perform
lumbar
punctur
young
febril
infant
document
viral
infect
especi
younger
month
age
addit
ed
pecarn
larg
tertiari
care
academ
institut
practic
pattern
includ
test
viral
pathogen
well
evalu
sbi
may
repres
practic
pattern
commun
ed
primari
care
pediatr
offic
final
american
academi
pediatr
propos
updat
definit
uti
requir
presenc
abnorm
urinalysi
posit
urin
cultur
defin
least
cfu
ml
pathogen
bacterium
use
definit
studi
cohort
guidelin
appli
infant
older
month
age
summari
febril
infant
day
age
younger
document
viral
infect
significantli
lower
risk
sbi
similarli
age
febril
infant
test
neg
viral
infect
nevertheless
risk
sbi
nonneglig
virusposit
infant
particularli
uti
approxim
infant
document
viru
infect
first
month
life
bacteremia
andor
bacteri
mening
therefor
conclud
presenc
document
viral
ill
affect
initi
ed
evalu
sbi
febril
infant
day
age
younger
second
month
life
minimum
evalu
uti
would
prudent
febril
infant
document
viral
infect
well
low
threshold
maintain
test
bacteremia
mening
